Therefore, we propose that efficient PR-B-mediated effects require PTEN action and that the PR-B/PTEN functional interplay has the ability to modulate cell survival signalling, extending the beneficial role of this nuclear receptor on breast cancer cells. This evidence concerns the gene PTEN and breast cancer.